NSE / BSEHealthcare
β‚Ή193.70-8.65-4.27%
P/E442.0Mkt Capβ‚Ή24.71 K CrEV/EBITDA164.0

Pine Labs Limited

P/E442.0Mkt Capβ‚Ή24.71 K CrEV/EBITDA164.0
Company Profile

Pine Labs Limited, a technology company, provides digital payments and issuing solutions for merchants, consumer brands and enterprises, and financial institutions in India, Malaysia, the United Arab Emirates, Singapore, Australia, the United States, and Africa. It operates through Digital Infrastructure and Transaction Platform, and Issuing and Acquiring Platform segments. The Digital Infrastructure and Transaction Platform segment provides technology platforms under the brand name of Pinelabs, Mosambee, Benow, Setu, Qfix, and Fave to merchants that enables acceptance of instore or online digital payments. These technology platforms and infrastructure allow merchants to accept debit cards, credit cards, prepaid instruments wallets, QR codes, unified payment interface, loyalty points, pay later, online fee collection, etc., as well as provide application programming interface modules to customers for building financial products that facilitates bill payments, credit, and savings to enable purchases made by consumers. It also engages in selling digital checkout points devices. The Issuing and Acquiring Platform segment provides a technology platform to issue, process, and distribute prepaid cards primarily in India and South East Asia. It also monetizes primarily by charging a processing fee from merchants who are utilizing the technology platform and in the case of distribution. The company was incorporated in 1998 and is based in Gurugram, India.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 15 Sept 2026
P/E Ratio
0.0x
β€”
P/B Ratio
β€”
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
0.0x
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
0.0x
β€”

AI Summary

Indian Stock

Strengths1

  • Revenue grew 19.8% YoY

Concerns1

  • Low interest coverage ratio of 1.8x

Rule-based from financial data. Not advice.

Price Historyβ–Ό 22.92% over 1Y

Monthly Returns

Unlock Monthly Returns

Available on Pro and Institutional plans.

Sign up free

Year-to-Date ROI

Unlock Year-to-Date ROI

Available on Pro and Institutional plans.

Sign up free

Historical Volatility

Unlock Historical Volatility

Available on Pro and Institutional plans.

Sign up free

Historical Performance

Revenue, profitability, and cash flow trends (β‚Ή Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenueβ‚Ή1.60 K Crβ–² 19.8%
EBITDA Growthβ€”
Net Profitβ‚Ή44.00 Crβ–Ό 123.5%
Cash from Ops (CFO)β€”
Free Cash Flow (FCF)β€”β–² 244.0%
Revenue CAGR 5Y15.0%
EBITDA CAGR 5Y15.2%
Net Profit CAGR 5Y0.0%
NP Growth 1Y-123.5%

Historical Growth

Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 6 years)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025β‚Ή1.60 K Crβ€”β‚Ή44.00 Crβ€”β€”2.1%19.8%-123.5%
Mar 2024β‚Ή1.33 K Crβ€”β‚Ή-187.00β€”β€”-9.1%4.1%233.9%
Mar 2023β‚Ή1.28 K Crβ€”β‚Ή-56.00β€”β€”-2.6%37.4%143.5%
Mar 2022β‚Ή932.00 Crβ€”β‚Ή-23.00β€”β€”-1.2%43.4%-58.9%
Mar 2021β‚Ή650.00 Crβ€”β‚Ή-56.00β€”β€”-4.7%-2.1%69.7%
Mar 2020β‚Ή664.00 Crβ€”β‚Ή-33.00β€”β€”-3.1%β€”β€”

Financial Statements

Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

Free plan Β· showing 1 year of data.Upgrade

Consolidated Figures in USD Millions.

Unnamed: 0Mar 2025
Revenue / Net Sales1,597
Total Expenses1,356
EBIT / Operating Profit241
OPM %15%
Other Income98
Finance Costs70
Depreciation & Amortisation210
Profit Before Tax58
Tax %26%
Net Profit / PAT44
EPS (β‚Ή)0.52
Dividend Payout %0%

Peer Comparison

Healthcare sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
Pine Labs Limitedthis co.β‚Ή24.71 K Crβ‚Ή1.60 K Cr442.000.00164.0119.8%
Sun Pharmaceutical Industries Ltd.β‚Ή4.15 L Crβ‚Ή23.00 K Cr88.7017.4372.3013.5%
Divi's Laboratories Ltd.β‚Ή1.71 L Crβ‚Ή9.20 K Cr67.9011.1367.2120.0%
Torrent Pharmaceuticals Ltd.β‚Ή1.33 L Crβ‚Ή9.68 K Cr62.5015.7645.6413.5%
Cipla Ltd.β‚Ή1.17 L Crβ‚Ή19.05 K Cr22.503.5119.3314.9%
Apollo Hospitals Enterprises Ltd.β‚Ή1.05 L Crβ‚Ή8.20 K Cr75.0011.2854.4412.8%
Max Healthcare Institute Limitedβ‚Ή1.00 L Crβ‚Ή2.66 K Cr144.0011.7696.8413.8%
Industry Averageβ€”β‚Ή3.29 K Cr98.638.1165.5020.2%

Learn while you research

Hand-picked academy chapters to deepen your understanding of Pine Labs Limited and the metrics that matter.

Browse the full Equiscale Academy